Search clinical trials for: Liquid CAIV-T

Total 9799 results

MedImmune LLC

Completed

Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants

Healthy

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children

Healthy

Philippines, Thailand
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children

Healthy

China
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)

Influenza

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children (CAIVT)

Influenza

United States
MedImmune LLC

Completed

Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age

Influenza

United States, United Kingdom, Belgium, Czechia, Hong Kong, Ireland, Korea, Republic of, Taiwan
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children.

Influenza
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults

Influenza

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants

Healthy

Finland
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months

Influenza

Singapore
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.

Healthy
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)

Influenza

Australia
MedImmune LLC

Completed

Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)

Influenza

Finland
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older

Influenza

South Africa
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children (FluMist)

Healthy

Finland, Belgium
MedImmune LLC

Completed

Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)

Influenza

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers

Influenza

Finland
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma

Asthma

Belgium
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older

Influenza

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children

Respiratory Tract Infections

Spain, Israel
National Institute of Allergy and Infectious Diseases...
Aviron LLC

Completed

Study of a Flu Vaccine in Children

Influenza

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.

Influenza

United States
MedImmune LLC

Completed

A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children

Healthy

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years. (FluMist)

Influenza

Belgium, Poland, United Kingdom
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male Adults

Healthy Japanese Male Adults
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza (FluMist)

Influenza

South Africa
University of Zurich

Completed

Quality-of-Life Management for COPD Patients (CAir)

Copd | Chronic Respiratory Disease

Switzerland
Bangkok Metropolitan Administration Medical College...

Completed

FGF21 Can Help Predicting Arterial Stiffness Measured by Cardio-ankle Vascular Index in Renal Transplant Patients (CAVIFGF21)

Vascular Stiffness

Thailand
Cryobeauty
CEISO

Completed

Assessment of CRYOBEAUTY MAINS ET DECOLLETE Versus Liquid Nitrogen Cryotherapy, in the Treatment of Solar Lentigines (CBT-EC2)

Solar Lentigo

France
Samara Regional Cardiology Dispensary
Samara State Medical University

Recruiting

Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS (Combi-LLT ACS)

Dyslipidemias

Russian Federation
Pamukkale University

Completed

Arterial Stiffness in Type 2 Diabetic Patients With Severe Periodontitis

Diabetes Mellitus, Type 2 | Periodontitis | Coronary Heart Disease | Arterial Stiffness

Turkey
Novartis Vaccines

Completed

Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008

Seasonal Influenza Vaccine

Germany
University Medical Center Groningen

Not yet recruiting

Clinical Validation of the C-Arm Rotational View (CARV) to Avoid Rotational Malalignment After Intramedullary Nailing of Tibial Shaft Fractures.

Surgery | Tibial Fractures | Complication,Postoperative

Australia, Netherlands
Embo-Flüssigkeiten A.G.

Active, not recruiting

Treatment of Cerebral Arteriovenous Malformations With SQUID Liquid Embolic Agent (CHOICE) (CHOICE)

Cerebral Arteriovenous Malformation

France, Denmark, Germany, Belgium, Italy
Dr. Markus Alfred Möhlenbruch
University Hospital Schleswig-Holstein

Completed

Treatment of Dural Arteriovenous Fistulas With SQUID™ Liquid Embolic Agent (Liquid)

Dural Arteriovenous Fistula

Germany
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaborators

Completed

Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers

Smoking | Respiratory Tract Infections | Influenza, Human | Habits

United States
Seqirus

Withdrawn

Flucelvax Pregnancy Registry

Pregnant Women, Influenza

United States
University of North Carolina, Chapel Hill
National Institute of Environmental Health Sciences (NIEHS); Environmental...

Completed

Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without Allergies (FLAIR)

Allergic Rhinitis

United States
University of Texas at Austin

Recruiting

Cancer Pain Management Using a Web-based Intervention (CAI)

Depressive Symptoms | Cancer Pain | Cancer of Breast

United States
Research Institute of Influenza, Russia
World Health Organization; Institute of Experimental Medicine, Russia; Joint...

Unknown

Reactogenicity, Safety and Immunogenicity of a LAIV А/17/Hong Kong/2017/75108 H7N9 Influenza Vaccine

Vaccine Adverse Reaction
Amphivena Therapeutics, Inc.

Completed

A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes

Myelodysplastic Syndrome (MDS)

United States
Clear Guide Medical
The Cooper Health System

Completed

Computer Assisted Instrument Guidance (CAIG) for Orthopedic Peripheral Nerve Blocks

Peripheral Nerve Blocks

United States
Novartis
Novartis Vaccines

Completed

Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup

Influenza

Poland
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age (SLVP016)

Influenza

United States
Wake Forest University Health Sciences

Completed

Menthol and Mint Experimental Tobacco Marketplace (ETM) Study

Cigarette Smoking | Vaping

United States
Balgrist University Hospital

Completed

Evaluation of the Intraoperative Accuracy of 3D-planned and Guided Osteotomies of the Hand and Forearm (CARDFOREARM)

Posttraumatic or Congenital Bone Deformity

Switzerland
Marshfield Clinic Research Foundation
University of Wisconsin, Madison; Centers for Disease Control and Prevention

Completed

Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents

Influenza A Virus Infection | Influenza B Virus Infection | Immune Response to Influenza Vaccine

United States
University of California, Los Angeles
J. Craig Venter Institute

Completed

Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection

Influenza

United States
Sun Yat-sen University

Recruiting

Toripalimab Combined With CAV/IE Regimen

Soft Tissue Sarcoma

China
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States

3

Subscribe